InsiderTrades

Form 4 for NPCE NeuroPace Inc

Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0000899243-22-036949 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-11-23 2022-11-21+ NPCE Accelmed Partners II L.P. 10% P - Purchase $1.50 +390.3K 4.37M +10% +$585.4K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-22 P A 62,398 $1.50 4,432,948 D — —
2 Common Common Stock 2022-11-21 P A 327,893 $1.50 4,370,550 D — — (F1) Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.